Phase Holographic Announces Record Sales Growth

Phase Holographic (PHI), a leader in live cell imaging and analysis, has announced a revised outlook following the latest order intake from their global distributor, Altium SA. While the order placements in the latter half of the fiscal year remained robust, the final volumes slightly missed the company's earlier projections. Despite this, PHI has experienced a record-breaking year with a 50% increase in sales compared to the previous fiscal year, 2023/2024.

Acting CEO Patrik Eschricht expressed optimism, stating that the sales growth is a clear indicator of the increasing demand for PHI's innovative solutions. The fiscal year 2024/2025 concluded on April 30, 2025, and a detailed financial performance report is expected to be released in June 2025.

This growth trajectory suggests a promising future for PHI as it continues to expand its market presence. The company's commitment to innovation and quality has been pivotal in driving demand, and the revised outlook should be seen as a strategic recalibration rather than a setback.

For investors, the current scenario presents a compelling case to hold onto PHI shares. The company's consistent growth, coupled with the potential for further expansion in the live cell imaging sector, makes it a promising long-term investment. While the missed projections may cause short-term fluctuations, the overall trend remains positive.

In conclusion, Phase Holographic's achievements over the past fiscal year underscore its resilience and capacity for growth. Investors are advised to hold their positions as the company releases its detailed financial report and continues to capitalize on the growing demand for its cutting-edge solutions.